Please Note: This trial is no longer enrolling new participants
Phase Ib Active Immunotherapy Trial (Expansion) with a Combination of Two Chimeric (Trastuzumab-like and Pertuzumab-like) HER-2 B Cell Peptide Vaccine emulsified in ISA 720 Adjuvant in Patients with Advanced Solid Tumors
Protocol No. | CTO-IUSCCC-09138 | Scope | Local |
---|---|---|---|
Principal Investigator | Pravin Kaumaya | Treatment Type | Treatment |
Age Group | Adult | Phase | Phase I |